The findings of this study suggest that VRK2 activates the transcription of NF-κB by phosphorylating IKKβ, thereby promoting the growth of pancreatic cancer cells and enhancing their tumorigenic ability in vivo (Fig. 8). The gene discussed is VRK2; the disease is familial pancreatic carcinoma.